← Scroll for more →
Financial Statements — EBRCZ
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 59.35 | 6.56 | 5.79 | 12.64 | 44.99 | 8.90 | 6.92 | 36.41 |
| Short-term Investments | 26.59 | 23.32 | 47.40 | 55.72 | 36.70 | 38.97 | 53.75 | 37.18 |
| Accounts Receivable | -- | -- | -- | -- | -- | 0.03 | -- | -- |
| Inventory | 17.59 | 15.49 | 13.79 | 9.69 | 5.13 | 4.72 | 2.84 | 1.20 |
| Total Current Assets | 110.15 | 54.04 | 73.11 | 82.23 | 90.35 | 53.48 | 64.47 | 74.61 |
| Property, Plant & Equipment | 9.20 | 8.77 | 5.48 | 3.19 | 3.01 | 1.24 | 0.79 | 0.92 |
| Total Non-current Assets* | 28.53 | 26.24 | 24.12 | 22.76 | 24.59 | 22.02 | 9.09 | 4.21 |
| Total Assets | 138.68 | 80.29 | 97.23 | 104.99 | 114.93 | 75.50 | 73.56 | 78.82 |
| Accounts Payable | 4.10 | 5.77 | 7.05 | 4.59 | 4.77 | 2.75 | 3.25 | 2.01 |
| Total Current Liabilities | 52.02 | 12.07 | 14.05 | 10.35 | 9.69 | 6.73 | 8.33 | 6.72 |
| Long-term Debt | 41.80 | 41.80 | 41.80 | 41.80 | 41.80 | 41.81 | 41.84 | 41.86 |
| Total Non-current Liabilities* | 17.80 | 58.68 | 57.59 | 55.99 | 55.55 | 54.22 | 40.88 | 40.86 |
| Total Liabilities | 69.82 | 70.75 | 71.64 | 66.34 | 65.23 | 60.94 | 49.20 | 47.59 |
| Retained Earnings | (436.74) | (419.29) | (402.22) | (388.17) | (375.98) | (364.01) | (353.46) | (343.36) |
| Total Stockholder Equity | 68.86 | 9.54 | 25.59 | 38.65 | 49.70 | 14.56 | 24.36 | 31.24 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.64 | 2.36 | 0.94 | 0.51 | 0.17 | -- | -- | -- |
| Cost of Revenue | 2.29 | 2.18 | 0.75 | 0.29 | 0.09 | -- | -- | -- |
| Gross Profit | 0.34 | 0.18 | 0.18 | 0.22 | 0.08 | -- | -- | -- |
| Research & Development | 6.62 | 6.42 | 6.33 | 6.24 | 5.95 | 5.42 | 6.89 | 6.30 |
| Selling, General & Admin | 10.12 | 9.94 | 7.15 | 5.86 | 5.26 | 4.36 | 2.93 | 2.88 |
| Total Operating Expenses | 16.74 | 16.36 | 13.47 | 12.10 | 11.22 | 9.78 | 9.83 | 9.18 |
| Operating Income | (16.40) | (16.17) | (13.29) | (11.88) | (11.13) | (9.78) | (9.83) | (9.18) |
| Interest Expense | 1.34 | 1.32 | 1.39 | 1.43 | 1.43 | 1.40 | 1.47 | 1.53 |
| Pretax Income | (17.45) | (17.07) | (14.05) | (12.19) | (11.97) | (10.55) | (10.10) | (10.06) |
| Tax Provision | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (17.45) | (17.07) | (14.05) | (12.19) | (11.97) | (10.55) | (10.10) | (10.06) |
| Basic EPS | (0.35) | (0.38) | (0.03) | (0.03) | (0.03) | (0.03) | (0.03) | (0.03) |
| Diluted EPS | (0.35) | (0.38) | (0.03) | (0.03) | (0.03) | (0.03) | (0.03) | (0.03) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (17.19) | (20.25) | (15.01) | (13.14) | (11.48) | (13.56) | (10.99) | (30.24) |
| Capital Expenditures | 2.85 | 3.29 | 1.46 | 1.28 | 0.89 | 0.06 | 0.07 | 0.21 |
| Free Cash Flow* | (20.05) | (23.54) | (16.47) | (14.42) | (12.36) | (13.62) | (11.05) | (30.45) |
| Investing Cash Flow | (6.18) | 20.88 | 8.12 | (19.08) | 0.90 | 17.91 | (21.17) | 22.28 |
| Financing Cash Flow | 76.19 | 0.13 | 0.06 | (0.14) | 46.67 | 0.24 | 2.68 | 29.80 |
← Scroll for more columns →
* Derived from reported values